Randomised clinical trial: the 5‐HT4 agonist revexepride in patients with gastro‐oesophageal reflux disease who have persistent symptoms despite PPI therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|41|7|649-661

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.7, 2015-04, pp. : 649-661

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized clinical trial: effect of the 5‐HT4 receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 2, 2015-02 ,pp. : 258-268

John Wiley & Sons Inc

Access to resources Recommend Favorite

Electrical stimulation therapy of the lower oesophageal sphincter for refractory gastro‐oesophageal reflux disease – interim results of an international multicentre trial

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 5, 2015-09 ,pp. : 614-625

John Wiley & Sons Inc

Access to resources Recommend Favorite

Identifying gastro-oesophageal reflux disease in infants

By Patience Sara  

Community Practitioner, Vol. 85, Iss. 11, 2012-11 ,pp. : 46-48

Community Practitioner

Access to resources Recommend Favorite

Gastro-oesophageal reflux disease: a re-appraisal

By Jones Roger  

British Journal of General Practice, Vol. 56, Iss. 531, 2006-10 ,pp. : 739-740

Royal College of General Practitioners

Access to resources Recommend Favorite

Gastro‐oesophageal reflux disease and Helicobacter pylori infection

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 16, Iss. s1, 2002-03 ,pp. : 47-51

John Wiley & Sons Inc

Access to resources Recommend Favorite